Many insured children lack essential health care, study finds

20 November 2016 - Margo Solomon has health insurance for herself and her four children. ...

Read more →

GSK receives FDA approval for expanded indication for FluLaval Quadrivalent (influenza vaccine) for infants 6 months and older

18 November 2016 - GSK announced today it has received approval from the US FDA Center for Biologics Evaluation and ...

Read more →

Spectrum Pharmaceuticals says FDA rejects its bladder cancer drug

18 November 2016 - Spectrum Pharmaceuticals said on Friday the U.S. FDA had rejected its bladder cancer treatment, apaziquone. ...

Read more →

Seattle Genetics receives FDA breakthrough therapy designation for Adcentis (brentuximab vedotin) in mycosis fungoides and primary cutaneous anaplastic large cell lymphoma

10 November 2016 - Submission of supplemental biologics license application for Adcetris in CD30-expressing CTCL planned in first half of ...

Read more →

U.S. FDA grants fast track designation for the development of Eisai's BACE inhibitor E2609 for early Alzheimer's disease

18 November 2016 - Eisai announced today that the U.S. FDA has granted fast track designation for the development of the ...

Read more →

FDA research to help speed development of Zika virus vaccines and therapeutics

17 November 2016 - Neonatal mouse model provides a new platform for Zika virus research. ...

Read more →

FDA approves Intrarosa for postmenopausal women experiencing pain during sex

17 November 2016 - The U.S. FDA approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse ...

Read more →

The end of Obamacare

17 November 2016 - Donald Trump’s triumph in the 2016 presidential election marks the beginning of an uncertain and tumultuous chapter ...

Read more →

Maintaining insurance access under Trump — a strategy

16 November 2016 - Donald Trump’s election as President puts the future of the Affordable Care Act (ACA) in jeopardy.  ...

Read more →

Centrexion Therapeutics announces fast track designation granted by FDA to CNTX-4975 for treatment of Morton’s neuroma

15 November 2016 - CNTX-4975 has potential to be the first non-surgical FDA-approved treatment for orphan disease, painful foot nerve ...

Read more →

Amgen and Allergan submit biosimilar biologics license application for ABP 215 to U.S. FDA

15 November 2016 - Supported by phase 3 study in patients with non-squamous non-small-cell lung cancer. ...

Read more →

Drug makers to FDA: Let us share off-label study data with payers

16 November 2016 - Now that pharma has prevailed in free-speech legal battles concerning off-label marketing, it’s pushing the FDA ...

Read more →

How drug price pressure helped sink Novo's insulin pill

16 November 2016 - Commercial rather than technical hurdles ultimately torpedoed Novo Nordisk's bid to make an oral form of ...

Read more →

How to make drug prices fair to U.S. consumers

16 November 2016 - Americans pay far more for branded prescription drugs than people in any other developed nation, exactly ...

Read more →

Trump used to rail against drug prices. Now the industry's allies are helping shape his agenda

15 November 2016 - President-elect Donald Trump made the cost of prescription drugs a central part of his healthcare pitch while ...

Read more →